Bellevue Group »

Hemab Therapeutics Holdings shares owned by Bellevue Group

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Bellevue Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $20M 550k 36.73

More positions owned by Bellevue Group

Amgen (AMGN)
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Gilead Sciences (GILD)
Revolution Medicines (RVMD)
Oruka Therapeutics (ORKA)
Insmed Com Par $.01 (INSM)
Scholar Rock Hldg Corp (SRRK)
Nuvalent Inc-a (NUVL)
Miragen Therapeutics (VRDN)
Relay Therapeutics (RLAY)
Vaxcyte (PCVX)
United Therapeutics Corporation (UTHR)
Intuitive Surgical Com New (ISRG)
Regeneron Pharmaceuticals (REGN)

View all positions for Bellevue Group

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
FMR
Capital Research and Management Company - Division 3
venBio Select Advisor
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Driehaus Capital Management
Rock Springs Capital Management
Bellevue Group
Citadel Advisors
Deerfield Management Company
ExodusPoint Capital Management
Geode Capital Management

View all funds holding Hemab Therapeutics Holdings